z-logo
Premium
Presence of EBV‐DNA sequences in nasopharyngeal cells of individuals without IgA‐VCA antibodies
Author(s) -
Desgranges C.,
Pi G. H.,
Bornkamm G. W.,
Legrand C.,
Zeng Y.,
DeThé G.
Publication year - 1983
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910320504
Subject(s) - serology , antibody , dna , biology , titer , virus , epstein–barr virus , virology , dna sequencing , southern blot , immunology , microbiology and biotechnology , genetics
Exfoliated nasopharyngeal (NP) cells from 62 normal Cantonese Chinese having IgA/VCA antibodies for more than a year and from 39 similar persons without IgA/VCA antibodies, were tested for the presence of EBV/DNA sequences by spot followed by blot hybridization tests, using the cloned internal repeat of B95‐8 viral DNA as probe. Thirteen out of 62 specimens from IgA/VCA‐positive (21%) and six out of 39 specimens (15.4%) from IgA/VCA‐negative individuals were found to contain EBV/DNA sequences. Forty‐six cases (20 IgA/VCA‐positive and 26 IgA/VCA‐negative) were followed a year later for EBV/DNA sequences and EBV serology. Half of the individuals having EBV/DNA sequences in their exfoliated NP cells in 1981 did not have detectable EBV sequences a year later, and to out of 15 negative individuals became EBV/DNA‐positive. There was no obvious correlation between EBV/DNA detectability and EBV serology. (We conclude that the best marker for NPC risk remains the increasing IgA/VCA and/or EA antibody titers.)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom